SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,072 | -99.7% | 16,695 | -98.0% | 0.00% | -100.0% |
Q2 2023 | $1,017,425 | +58.7% | 851,402 | -8.2% | 0.02% | +50.0% |
Q1 2023 | $641,034 | -7.6% | 927,422 | -9.3% | 0.01% | -16.7% |
Q4 2022 | $693,943 | -45.3% | 1,022,008 | -17.0% | 0.01% | -50.0% |
Q3 2022 | $1,268,000 | +267.5% | 1,230,810 | +142.6% | 0.02% | +242.9% |
Q2 2022 | $345,000 | – | 507,416 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
Renaissance Technologies | 591,086 | $554,000 | 0.00% |